{"id":370,"date":"2018-07-12T07:00:38","date_gmt":"2018-07-12T07:00:38","guid":{"rendered":"https:\/\/advantagehcconsulting.com\/blog\/?p=370"},"modified":"2018-07-10T14:34:19","modified_gmt":"2018-07-10T14:34:19","slug":"diagnosis-coding-check-out-the-secondary-dx-groups-that-will-boost-pdgm-pay","status":"publish","type":"post","link":"https:\/\/advantagehcconsulting.com\/blog\/2018\/07\/12\/diagnosis-coding-check-out-the-secondary-dx-groups-that-will-boost-pdgm-pay\/","title":{"rendered":"Diagnosis Coding: Check Out The Secondary Dx Groups That Will Boost PDGM Pay"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-371 alignleft\" src=\"https:\/\/advantagehcconsulting.com\/blog\/wp-content\/uploads\/2018\/07\/Diagnosis-coding.jpg\" alt=\"\" width=\"259\" height=\"194\" srcset=\"https:\/\/advantagehcconsulting.com\/blog\/wp-content\/uploads\/2018\/07\/Diagnosis-coding.jpg 259w, https:\/\/advantagehcconsulting.com\/blog\/wp-content\/uploads\/2018\/07\/Diagnosis-coding-210x157.jpg 210w\" sizes=\"auto, (max-width: 259px) 100vw, 259px\" \/><\/p>\n<p><span style=\"color: #ffffff;\"><strong><em>CMS listened to HHGM commenters and revised the case mix category methodology.<\/em><\/strong><\/span><\/p>\n<p>The newly proposed payment reform model will increase payment for an episode when the claim contains certain secondary diagnoses.<\/p>\n<p><span style=\"color: #ffffff;\"><strong>To receive a \u201clow\u201d comorbidity adjustment under PDGM, an episode must have at least one code from the following 11 groups:<\/strong><\/span><\/p>\n<p>Neuro 11 (Includes diabetic retinopathy and other blindness)<br \/>\nNeuro 10 (Includes diabetic neuropathies)<br \/>\nCirculatory 9 (Includes acute and chronic embolisms and thrombosis)<br \/>\nHeart 11 (Includes heart failure)<br \/>\nCerebral 4 (Includes sequelae of cerebrovascular diseases)<br \/>\nNeuro 5 (Includes Parkinson\u2019s Disease)<br \/>\nSkin 1 (Includes cutaneous abscess, cellulitis, and lymphangitis)<br \/>\nNeuro 7 (Includes hemiplegia, paraplegia, and quadriplegia)<br \/>\nCirculatory 10 (Includes varicose veins with ulceration)<br \/>\nSkin 3 (Includes diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<br \/>\nSkin 4 (Includes stages Two-Four and unstageable pressure ulcers by site).<\/p>\n<p><span style=\"color: #ffffff;\"><strong>To receive a \u201chigh\u201d comorbidity adjustment under PDGM, an episode must have codes from at least one of the following 27 pairs of groups:<\/strong><\/span><\/p>\n<ul>\n<li>Circulatory 4 (Hypertensive Chronic Kidney Disease) and Neuro 11 (Includes diabetic retinopathy and other blindness)<\/li>\n<li>Endocrine 3 (Diabetes with Complications) and Neuro 7 (Includes hemiplegia, paraplegia, and quadriplegia)<\/li>\n<li>Neuro 3 (Dementia in diseases classified elsewhere) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Circulatory 4 (Hypertensive Chronic Kidney Disease) and Skin 1 (Cutaneous abscess, cellulitis, and lymphangitis)<\/li>\n<li>Cerebral 4 (Sequelae of Cerebrovascular Diseases Heart) and Heart 11 (Heart Failure)<\/li>\n<li>Neuro 7 (Includes hemiplegia, paraplegia, and quadriplegia) and Renal 3 (Nephrogenic Diabetes Insipidus)<\/li>\n<li>Circulatory 10 (Includes varicose veins with ulceration) and Endocrine 3 (Diabetes with Complications)<\/li>\n<li>Heart 11 (Heart Failure) and Neuro 5 (Parkinson\u2019s Disease)<\/li>\n<li>Heart 12 (Other Heart Diseases) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Neuro 3 (Dementia in diseases classified elsewhere) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Behavioral 2 (Mood Disorders) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Circulatory 10 (Includes varicose veins with ulceration) and Heart 11 (Heart Failure)<\/li>\n<li>Circulatory 4 (Hypertensive Chronic Kidney Disease) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Renal 1 (Chronic kidney disease and ESRD) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Respiratory 5 (COPD and Asthma) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Skin 1 (Cutaneous abscess, cellulitis, and lymphangitis) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Renal 3 (Nephrogenic Diabetes Insipidus) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Heart 11 (Heart Failure) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Heart 12 (Other Heart Diseases) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Respiratory 5 (COPD and Asthma) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Circulatory 7 (Atherosclerosis) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Renal 1 (Chronic kidney disease and ESRD) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Endocrine 3 (Diabetes with Complications) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Endocrine 3 (Diabetes with Complications) and Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers)<\/li>\n<li>Circulatory 4 (Hypertensive Chronic Kidney Disease) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Heart 11 (Heart Failure Skin) and Skin 4 (Stages Two-Four and unstageable pressure ulcers by site)<\/li>\n<li>Skin 3 (Diseases of arteries, arterioles and capillaries with ulceration and nonpressure chronic ulcers) and Skin 4) Stages Two-Four and unstageable pressure ulcers by site).<\/li>\n<\/ul>\n<p>Source: Tables 44 and 45, 2019 Home Health Prospective Payment System proposed rule.<\/p>\n<p><a href=\"https:\/\/www.supercoder.com\/coding-newsletters\/my-homecare-week-alert\/diagnosis-coding-check-out-the-secondary-dx-groups-that-will-boost-pdgm-pay-158149-article\"><i><span style=\"font-weight: 400;\">Source- SuperCoder<\/span><\/i><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CMS listened to HHGM commenters and revised the case mix category methodology. The newly proposed payment reform model will increase payment for an episode when the claim contains certain secondary &hellip; <a class=\"readmore\" href=\"https:\/\/advantagehcconsulting.com\/blog\/2018\/07\/12\/diagnosis-coding-check-out-the-secondary-dx-groups-that-will-boost-pdgm-pay\/\">Continue Reading &rarr;<\/a><\/p>\n","protected":false},"author":1,"featured_media":371,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[11,12,13,14],"class_list":["post-370","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reimbursement","tag-home-care","tag-hospice","tag-ltc","tag-snf"],"_links":{"self":[{"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/posts\/370","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/comments?post=370"}],"version-history":[{"count":1,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/posts\/370\/revisions"}],"predecessor-version":[{"id":372,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/posts\/370\/revisions\/372"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/media\/371"}],"wp:attachment":[{"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/media?parent=370"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/categories?post=370"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advantagehcconsulting.com\/blog\/wp-json\/wp\/v2\/tags?post=370"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}